Abstract
Regenerative medicine has quickly become an accepted medical therapeutic option for an ever-increasing array of clinical disorders. We report here a study evaluating the ability of adipose-derived mesenchymal stem cells and platelet-rich plasma to treat osteoarthritis in dogs. The study used eight dogs, treating 15 joints total. Each animal was evaluated prior to treatment, and then at intervals of 15, 30, 60, and 90 days post-treatment. The evaluations scored each dog for lameness in walking and trotting; testing range of motion and pain upon manipulation; and observing functional disability of each joint. Statistical significance was obtained in multiple evaluation measures of the treatment outcomes, warranting further investigation of the healing capabilities of adipose-derived mesenchymal stem cells and platelet-rich plasma as substantial components of regenerative medicine.
©2017 Hilty DH
